We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2002;162(22):2517. doi:10.1001/archinte.162.22.2517.
Text Size: A A A
Published online


Although high body mass index is an established risk factor for coronary heart disease, its role as an independent risk factor for stroke has been controversial. In a prospective study of over 21 000 US male physicians, obesity (defined as body mass index >30) was associated with a significant 2-fold increase in the risk of total stroke and its 2 major subtypes following a linear trend. Since body mass index is a modifiable risk factor, the prevention of stroke may be another benefit associated with preventing obesity in adults.


Several prospective studies have reported that weight loss or fluctuation in body weight (weight cycling) is associated with an increased risk of cardiovascular and all-cause mortality. This has raised concern that losing weight intentionally in older age might be hazardous to health. The findings from this prospective study of 5608 men who participated in the British Regional Heart Study suggest that the increased mortality risk associated with weight loss and weight fluctuation (cycling) is determined to a large extent by disadvantageous lifestyle factors and preexisting ill health. These findings have important clinical and public health implications and should reassure overweight and obese men that intentional weight loss or weight cycling in middle and older age is not harmful.


As part of the Atherosclerosis Risk in Communities Study, the race-specific incidence rates and risk factor prediction for coronary heart disease (CHD) were determined for black and white persons over 7 to 10 years of follow-up (1987-1997). Incidence of CHD was similar in black and white men and marginally higher in black women than in white women using standard definitions. Excluding revascularization procedures from the definition of CHD events revealed higher rates in blacks than in whites for both men and women. The same traditional risk factors were associated with CHD incidence in blacks as in whites. Hypertension appeared to be a more potent predictor and diabetes less predictive in blacks than in whites. Findings from this study, along with clinical trial evidence showing efficacy, support aggressive management of traditional risk factors in blacks as in whites. Particularly, this study supports aggressive management of hypertension in black women. Understanding the intriguing racial differences in risk factor prediction may be an important part of further elucidating the causes of CHD and may lead to better methods of preventing and treating CHD.


The relative value of thrombolysis and heparin for treatment of patients with pulmonary embolism is still a matter of debate. Agnelli et al performed a meta-analysis of studies comparing thrombolysis and heparin treatment in patients with pulmonary embolism with respect to the incidence of death, recurrence of pulmonary embolism, and major bleeding. The cumulative incidence of these adverse outcome events was similar in the 2 treatment groups. A risk reduction of 41% and 40% in favor of thrombolysis was observed for death and recurrence, respectively. When death and recurrence were analyzed together, a statistically significant risk reduction of 40% in favor of thrombolysis was observed. The rates of major bleeding were influenced by the thrombolytic regimens and by the use of invasive procedures, essentially pulmonary angiography. This was particularly the case for patients receiving thrombolytic treatment. The rate of intracranial bleeding in patients receiving thrombolysis for pulmonary embolism was 0.8%, similar to that reported in patients with myocardial infarction treated with thrombolysis. Findings from this meta-analysis showed that death and recurrences are reduced by thrombolysis with respect to heparin treatment. Excessive bleeding, which is mainly associated with invasive procedures, is the trade-off for the improved efficacy.

Place holder to copy figure label and caption

Approximate odds ratios and 95% confidence intervals for death, recurrence of pulmonary embolism, or major bleeding event.

Graphic Jump Location


Place holder to copy figure label and caption

Approximate odds ratios and 95% confidence intervals for death, recurrence of pulmonary embolism, or major bleeding event.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.